ID

42935

Descrizione

A Safety and Efficacy Trial of Aliskiren 150mg , 300 mg Compared to Ramipril 5mg, 10mg in the Elderly; ODM derived from: https://clinicaltrials.gov/show/NCT00368277

collegamento

https://clinicaltrials.gov/show/NCT00368277

Keywords

versioni (2)
  1. 06/04/17 06/04/17 -
  2. 17/09/21 17/09/21 -
Caricato su

17 settembre 2021

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Hypertension NCT00368277

Inglese

Eligibility Hypertension NCT00368277

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
male or female outpatients ≥ 65 years old.
Descrizione

Outpatients | Age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0029921
UMLS CUI [2]
C0001779
patients with essential hypertension with an mssbp ≥ 140 mmhg and < 180 mmhg, and msdbp < 110 mmhg at visits 2 and 3. (visit 201 was deleted by the administrative changes document.)
Descrizione

Essential Hypertension | Sitting systolic blood pressure mean | Sitting diastolic blood pressure mean

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0085580
UMLS CUI [2,1]
C1319893
UMLS CUI [2,2]
C0444504
UMLS CUI [3,1]
C1319894
UMLS CUI [3,2]
C0444504
patients must have had a difference in mssbp of ≤ 20 mmhg between visit 3 and the visit immediately prior to visit 3.
Descrizione

Sitting systolic blood pressure mean Timepoint Difference

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1319893
UMLS CUI [1,2]
C0444504
UMLS CUI [1,3]
C2348792
UMLS CUI [1,4]
C1705242
patients who were eligible and able to participate in the study, and who consented to do so after the purpose and nature of the investigation had been explained to them (written informed consent).
Descrizione

Study Subject Participation Status | Informed Consent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0021430
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of renal artery stenosis.
Descrizione

Renal Artery Stenosis

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0035067
known keith-wagener grade iii or iv hypertensive retinopathy.
Descrizione

Hypertensive Retinopathy Grade

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0152132
UMLS CUI [1,2]
C0441800
history of hypertensive encephalopathy.
Descrizione

Hypertensive Encephalopathy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0151620
current diagnosis of heart failure (new york heart association class iii-iv).
Descrizione

Heart failure New York Heart Association Classification

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0018801
UMLS CUI [1,2]
C1275491
history of transient ischemic cerebral attack or cerebrovascular accident within 6 months.
Descrizione

Transient Ischemic Attack | Cerebrovascular accident

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0007787
UMLS CUI [2]
C0038454
history of myocardial infarction, bypass surgery, or any percutaneous coronary intervention within 6 months.
Descrizione

Myocardial Infarction | Bypass surgery | Percutaneous Coronary Intervention

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0027051
UMLS CUI [2]
C1536078
UMLS CUI [3]
C1532338
current unstable angina pectoris. patients on a stable dose of oral or topical nitrates or beta blockers for angina were acceptable.
Descrizione

Angina, Unstable | Nitrate Oral Dose Stable | Nitrate Topical Dose Stable | Adrenergic beta-1 Receptor Antagonists Dose Stable

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0002965
UMLS CUI [2,1]
C0699857
UMLS CUI [2,2]
C1527415
UMLS CUI [2,3]
C0178602
UMLS CUI [2,4]
C0205360
UMLS CUI [3,1]
C0699857
UMLS CUI [3,2]
C1522168
UMLS CUI [3,3]
C0178602
UMLS CUI [3,4]
C0205360
UMLS CUI [4,1]
C0304516
UMLS CUI [4,2]
C0178602
UMLS CUI [4,3]
C0205360
concurrent potentially life threatening arrhythmia or symptomatic arrhythmia.
Descrizione

Cardiac Arrhythmia Life Threatening | ARRHYTHMIA SYMPTOMATIC

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0003811
UMLS CUI [1,2]
C2826244
UMLS CUI [2]
C0741212
clinically significant valvular heart disease.
Descrizione

Heart valve disease

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0018824
concurrent use of any antihypersensitive medications except a stable dose 3 months prior to visit 1 of alpha adrenergic blockers for benign prostatic hypertrophy (e.g., flomax for bph), beta blockers for angina, or beta blockers ophthalmic preparations.
Descrizione

Antihypertensive Agents | Adrenergic alpha-Antagonists Dose Stable | Benign prostatic hypertrophy | Flomax | Adrenergic beta-1 Receptor Antagonists | Angina Pectoris | Adrenergic beta-1 Receptor Antagonists Ophthalmic

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0003364
UMLS CUI [2,1]
C0001641
UMLS CUI [2,2]
C0178602
UMLS CUI [2,3]
C0205360
UMLS CUI [3]
C1704272
UMLS CUI [4]
C0662903
UMLS CUI [5]
C0304516
UMLS CUI [6]
C0002962
UMLS CUI [7,1]
C0304516
UMLS CUI [7,2]
C1522230
Ritorna all'inizio della pagina

Similar models

Eligibility Hypertension NCT00368277

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Outpatients | Age
Item
male or female outpatients ≥ 65 years old.
boolean
C0029921 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Essential Hypertension | Sitting systolic blood pressure mean | Sitting diastolic blood pressure mean
Item
patients with essential hypertension with an mssbp ≥ 140 mmhg and < 180 mmhg, and msdbp < 110 mmhg at visits 2 and 3. (visit 201 was deleted by the administrative changes document.)
boolean
C0085580 (UMLS CUI [1])
C1319893 (UMLS CUI [2,1])
C0444504 (UMLS CUI [2,2])
C1319894 (UMLS CUI [3,1])
C0444504 (UMLS CUI [3,2])
Sitting systolic blood pressure mean Timepoint Difference
Item
patients must have had a difference in mssbp of ≤ 20 mmhg between visit 3 and the visit immediately prior to visit 3.
boolean
C1319893 (UMLS CUI [1,1])
C0444504 (UMLS CUI [1,2])
C2348792 (UMLS CUI [1,3])
C1705242 (UMLS CUI [1,4])
Study Subject Participation Status | Informed Consent
Item
patients who were eligible and able to participate in the study, and who consented to do so after the purpose and nature of the investigation had been explained to them (written informed consent).
boolean
C2348568 (UMLS CUI [1])
C0021430 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Renal Artery Stenosis
Item
history of renal artery stenosis.
boolean
C0035067 (UMLS CUI [1])
Hypertensive Retinopathy Grade
Item
known keith-wagener grade iii or iv hypertensive retinopathy.
boolean
C0152132 (UMLS CUI [1,1])
C0441800 (UMLS CUI [1,2])
Hypertensive Encephalopathy
Item
history of hypertensive encephalopathy.
boolean
C0151620 (UMLS CUI [1])
Heart failure New York Heart Association Classification
Item
current diagnosis of heart failure (new york heart association class iii-iv).
boolean
C0018801 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
Transient Ischemic Attack | Cerebrovascular accident
Item
history of transient ischemic cerebral attack or cerebrovascular accident within 6 months.
boolean
C0007787 (UMLS CUI [1])
C0038454 (UMLS CUI [2])
Myocardial Infarction | Bypass surgery | Percutaneous Coronary Intervention
Item
history of myocardial infarction, bypass surgery, or any percutaneous coronary intervention within 6 months.
boolean
C0027051 (UMLS CUI [1])
C1536078 (UMLS CUI [2])
C1532338 (UMLS CUI [3])
Angina, Unstable | Nitrate Oral Dose Stable | Nitrate Topical Dose Stable | Adrenergic beta-1 Receptor Antagonists Dose Stable
Item
current unstable angina pectoris. patients on a stable dose of oral or topical nitrates or beta blockers for angina were acceptable.
boolean
C0002965 (UMLS CUI [1])
C0699857 (UMLS CUI [2,1])
C1527415 (UMLS CUI [2,2])
C0178602 (UMLS CUI [2,3])
C0205360 (UMLS CUI [2,4])
C0699857 (UMLS CUI [3,1])
C1522168 (UMLS CUI [3,2])
C0178602 (UMLS CUI [3,3])
C0205360 (UMLS CUI [3,4])
C0304516 (UMLS CUI [4,1])
C0178602 (UMLS CUI [4,2])
C0205360 (UMLS CUI [4,3])
Cardiac Arrhythmia Life Threatening | ARRHYTHMIA SYMPTOMATIC
Item
concurrent potentially life threatening arrhythmia or symptomatic arrhythmia.
boolean
C0003811 (UMLS CUI [1,1])
C2826244 (UMLS CUI [1,2])
C0741212 (UMLS CUI [2])
Heart valve disease
Item
clinically significant valvular heart disease.
boolean
C0018824 (UMLS CUI [1])
Antihypertensive Agents | Adrenergic alpha-Antagonists Dose Stable | Benign prostatic hypertrophy | Flomax | Adrenergic beta-1 Receptor Antagonists | Angina Pectoris | Adrenergic beta-1 Receptor Antagonists Ophthalmic
Item
concurrent use of any antihypersensitive medications except a stable dose 3 months prior to visit 1 of alpha adrenergic blockers for benign prostatic hypertrophy (e.g., flomax for bph), beta blockers for angina, or beta blockers ophthalmic preparations.
boolean
C0003364 (UMLS CUI [1])
C0001641 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
C1704272 (UMLS CUI [3])
C0662903 (UMLS CUI [4])
C0304516 (UMLS CUI [5])
C0002962 (UMLS CUI [6])
C0304516 (UMLS CUI [7,1])
C1522230 (UMLS CUI [7,2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial